Ohio’s medical marijuana program saw a 43% decline in active patients from May 2024 to July 2025

OG Article By Megan Henry

October 09 2025

Declining Satisfaction

• 56% of surveyed patients are satisfied with Ohio’s Medical Cannabis Control Program (OMMCP) in 2025.

• Down from 74% in 2024.

• Dissatisfaction rose to 30% in 2025, up from 20% in 2024.

“That’s a pretty big drop,” said Jana Hrdinová, administrative director of the Drug Enforcement and Policy Center.

Patient Numbers Drop

• Active medical cannabis patients fell 43% from May 2024 (165,746) to July 2025 (94,294).

• Peak patient count was 184,958 in October 2023.

• 56% of patients are extremely likely to stay registered; 16% are somewhat likely.

Recreational Impact

• Ohio legalized recreational cannabis in 2023 with 57% voter approval.

• Recreational sales began August 2024, reaching $702.5 million in the first year.

• Medical cannabis sales since January 2019 total $2.23 billion, with 331,341 pounds sold.

Rising Costs

• Medical cannabis plant products cost $7.42 per gram in 2025, up from $6.16 in 2024.

• Michigan’s recreational flower averages $2.52 per gram, creating frustration for Ohio patients.

“If you drive to Michigan, you pay way less,” Hrdinová said.

Health Benefits

• 79% of patients report reduced need for prescription painkillers.

• 26% say cannabis helps reduce illegal drug use.

“There’s public and private benefit in replacing other substances with cannabis,” Hrdinová noted.

Policy Recommendations

• Regulate intoxicating hemp products with:

  • 21-year-old age requirement.

  • Safety and production standards.

  • No marketing to children.

• Collect data and fund Ohio-specific research.

• Educate the public on cannabis use.

Future Outlook

• Patient numbers may drop further before stabilizing.

• Medical patients value their distinct status from recreational users.

Follow OCJ Reporter Megan Henry on Bluesky.